Summary
ADP-induced platelet aggregation was measured in 15 Type 1 (insulin-dependent) diabetic patients, 15 Type 2 (non-insulin-dependent) diabetic patients and in 15 non-diabetic control subjects. Simultaneous measurements were made of fasting blood glucose, glycosylated haemoglobin, serum insulin, total plasma cholesterol, cholesterol in the lipoprotein subfractions, total triglycerides and platelet phospholipid fatty acid levels. Regression analysis of aggregation against the biochemical variables within the three groups revealed that there was no significant difference in the associations with aggregation between the groups. When the data was pooled, blood glucose (p<0.01) and glycosylated haemoglobin (p<0.05) demonstrated significant associations with aggregation. Multiple regression analysis was then applied; only blood glucose (p<0.05) had an independent effect on aggregation. Platelet aggregation in diabetic patients and non-diabetic patients appears to be related directly only to blood glucose levels.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Szirtes M (1970) Platelet aggregation in diabetes mellitus. Adv Cardiol 4:179–186
Sagel J, Colwell JA, Crook L, Laimins M (1975) Increased platelet aggregation in early diabetes mellitus. Ann Intern Med 82:733–738
Julian I, Buonocore M, Jove R, Vague PH, Moulin JP, Vialettes B (1982) Abnormalities of erythrocyte deformability and platelet aggregation in insulin dependent diabetics corrected by insulin in vivo and in vitro. Lancet 1:535–539
Marcus AJ (1978) The role of lipids in platelet function with particular reference to the arachidonic acid pathway. J Lipid Res 19:793–820
Evans RJ, Lane J, Holman RR, Turner RC (1982) Induced basal normoglycaemia and altered platelet aggregation in non-insulin dependent diabetes. Diabetes Care 5:433–437
Giugliano D, Misso L, Tirelli A, Coppola L, Di Pinto P, Torella R (1982) Platelet aggregation after strict metabolic control using the artificial pancreas. Diabetologia 23: p 545
Eldor A, Merin S, Baron H (1978) The effect of streptozotocin diabetes on platelet function in rats. Thromb Res 13:703–714
Moncada S, Vane JR (1977) Arachidonic acid metabolites and the interactions between platelets and blood vessel walls. N Engl J Med 300:1142–1147
Halushka RV, Rogers RC, Loadholt CB, Colwell JA (1981) Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med 97:87–96
Ylikorkala O, Kaila I, Viinikka J (1981) Prostacyclin and thromboxane in diabetes. Br Med J 283:1148–1150
Jones DB, Carter RD, Haitas B, Mann JI (1983) Low arachidonic acid values in diabetic platelets. Br Med J 286:173–175
Dyerberg J, Bang HO, Aagaard O (1980) Alpha linolenic acid and eicosapentaenoic acid. Lancet 1:199
Raz A, Minkes MS, Needleman P (1977) Endoperoxides and thromboxanes — structural determinants for platelet aggregation and vasoconstriction. Biochem Biophys Acta 488:305–311
Jones DB, Haitas B, Carter RD, Bown E, Mann JI (1984) Prostaglandin synthesis inhibition reduces platelet aggregation in diabetes mellitus. Horm Met Res 17:42–43
Hampton JR (1985) Platelets and coronary disease: round three. Br Med J 290:414–415
Jeppson JO, Franze B, Gaal AB (1980) Simplified determination of haemoglobin A1c in diabetic patients by use of isoelectric focussing. In: Radola BS (ed) Electrophoresis 1979. Advanced methods: biochemical and clinical applications. Walter de Gruyter, Berlin
Albano JDM, Ekins RP, Maritz G, Turner RC (1972) A sensitive precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free moieties. Acta Endocrinol 70:487–509
Ononogba IC, Lewis B (1976) Lipoprotein fraction by a precipitation method: a simple quantitative procedure. Clin Chem Acta 71:397–402
Burstein M, Scholnick HR, Morfin R (1970) Rapid method for the isolation of lipoproteins from human serum. Precipitation with polyanions. J Lipid Res 11:583–595
Wahlefeld AW (1974) Triglycerides: determination after enzymatic hydrolysis. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York London, p 1836
Lawrence RD (1963) Treatment of 90 severe diabetics with soluble insulin for 20–40 years. Effect of diabetic control on complications. Br Med J 2:1624–1626
Doman TL, Mann JI, Turner RC (1982) Factors protective against retinopathy in insulin dependent diabetics free of retinopathy for 30 years. Br Med J 285:1073–1077
Karpatkin S (1967) Studies on human platelet glycolysis. Effect of glucose, cyanide, insulin, citrate and agglutination and contraction on platelet glycolysis. J Clin Invest 46:409–414
Karpatkin S, Charmatz A, Langer RM (1970) Glycogenesis and glyconeogenesis in human platelets. Incorporation of glucose, pyruvate, and citrate into platelet glycogen: glycogen synthetase and fructose 1–6 diphosphatase activity. J Clin Invest 49:140–149
Brenner RR (1971) The desaturation step in the animal biosynthesis of polyunsaturated fatty acids. Lipids 6:567–575
Jones DB, Haitas B, Bown EG, Carter RD, Barker K, Jelfs R, Turner RC, Mann JI, Prescott RJ (1986) Platelet aggregation in non-insulin dependent diabetes is associated with platelet fatty acids. Diabetic Med 3:52–55
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jones, D.B., Davis, T.M.E., Bown, E. et al. Determinants of ADP-induced platelet aggregation in diabetes mellitus. Diabetologia 29, 291–294 (1986). https://doi.org/10.1007/BF00452065
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00452065